Boston Scientific Corp. vs. LeMaitre Vascular, Inc.
Boston Scientific Corp. (BSX) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| BSX | LMAT | |
|---|---|---|
| Market Cap | $60.84 billion | $1.85 billion |
BSX leads on 1 of 1 size & scale factors.
Dividend
| BSX | LMAT | |
|---|---|---|
| Dividend Yield | — | 1.24% |
BSX and LMAT split the dividend factors evenly.
Risk & Sentiment
| BSX | LMAT | |
|---|---|---|
| Short Interest | 0.72% | 4.36% |
BSX leads on 1 of 1 risk & sentiment factors.
Dig deeper: BSX overview, BSX financials, LMAT overview, LMAT financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.
